Results of an enhanced-outreach programme of hepatitis B vaccination in the Netherlands (1998-2000) among men who have sex with men, hard drug users, sex workers and heterosexual persons with multiple partners

被引:44
作者
van Steenbergen, JE
机构
[1] Municipal Hlth Serv Amsterdam GC&GD, NL-1000 CE Amsterdam, Netherlands
[2] Natl Coordinat Communicable Dis Control, Utrecht, Netherlands
关键词
hepatitis B; vaccination program; high-risk groups; evaluation;
D O I
10.1016/S0168-8278(02)00213-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The Dutch Ministry of Health funded a pilot vaccination project targeting groups at high risk for sex- and drug-related hepatitis B transmission. Methods: In seven Municipal Health Service (MHS) areas, three-part hepatitis B vaccination was offered free to men who have sex with men (MSM), drug users (DUs), and heterosexuals with multiple partners, including sex workers (SWs). Four intervention areas recruited participants through care-givers and opinion leaders and offered vaccination at non-MHS sites. Three control areas only used flyers to offer vaccination at MHS during regular hours. Results: Over 18 months, 13 808 persons enrolled for the first vaccination, representing 63% of the targeted population in the intervention areas and 23% in control areas. In intervention areas, only 19% of DUs enrolled, versus 4% in control areas. In both areas, enrollment of the targeted heterosexual population (64%) was satisfactory. MSM were most compliant in having the full series. Of vaccination sources, general practitioners (GPs) attained highest compliance (71%, odds ratio 1.82). Conclusions: Dutch MHS facilities can reach high-risk individuals, but DUs require additional outreach. Vaccine coverage was disappointing, but our experience will be deployed nationwide and successful strategies might be employed elsewhere in countries of low endemicity. (C) 2002 European Associaton for the Study of the Liver. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:507 / 513
页数:7
相关论文
共 34 条
[1]   Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey [J].
Allwright, S ;
Bradley, F ;
Long, J ;
Barry, J ;
Thornton, L ;
Parry, JV .
BRITISH MEDICAL JOURNAL, 2000, 321 (7253) :78-82
[2]  
BARTELDS AIM, 1998, CONTINUOUS REGISTRAT
[3]   FAILURE TO DELIVER HEPATITIS-B VACCINE - CONFESSIONS FROM A GENITOURINARY MEDICINE CLINIC [J].
BHATTI, N ;
GILSON, RJC ;
BEECHAM, M ;
WILLIAMS, P ;
MATTHEWS, MP ;
TEDDER, RS ;
WELLER, IVD .
BRITISH MEDICAL JOURNAL, 1991, 303 (6794) :97-101
[4]  
BRISSETTE S, 2000, ANTIVIR THER S, V5, P2
[5]  
Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P388
[6]  
DEGRAAF R, 1995, THESIS U AMSTERDAM
[7]   Factors associated with hepatitis B vaccination among men having sexual relations with men in Montreal, Quebec, Canada [J].
Dufour, A ;
Remis, RS ;
Alary, M ;
Otis, J ;
Mâsse, B ;
Turmel, B ;
Vincelette, J ;
Lavoie, R ;
LeClerc, R ;
Parent, R .
SEXUALLY TRANSMITTED DISEASES, 1999, 26 (06) :317-324
[8]  
Fennema J S, 2000, Ned Tijdschr Geneeskd, V144, P602
[9]   Factors influencing a communitywide campaign to administer hepatitis A vaccine to men who have sex with men [J].
Friedman, MS ;
Blake, PA ;
Koehler, JE ;
Hutwagner, LC ;
Toomey, KE .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (12) :1942-1946
[10]   Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: Implications for vaccination programs [J].
Goldstein, ST ;
Alter, MJ ;
Williams, IT ;
Moyer, LA ;
Judson, FN ;
Mottram, K ;
Fleenor, M ;
Ryder, PL ;
Margolis, HS .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (06) :713-719